(TOP (S (NP (NNP Immunex) (NNP Corp.)) (VP (VBD said) (SBAR (S (NP (PRP$ its) (NNS scientists)) (VP (VBD isolated) (NP (NP (DT a) (NN molecule)) (SBAR (WHNP (WDT which)) (S (VP (MD may) (VP (VB hold) (NP (NN potential)) (PP (IN as) (NP (NP (DT a) (NN treatment)) (PP (IN for) (NP (NP (NNS disruptions)) (PP (IN of) (NP (DT the) (NN immune-system))) (, ,) (VP (VBG ranging) (PP (PP (IN from) (NP (JJ organ-transplant) (NN rejection))) (, ,) (PP (TO to) (NP (NNS allergies) (CC and) (NN asthma)))))))))))))))))) (. .)) )
(TOP (S (NP (DT The) (NN molecule)) (VP (AUX is) (NP (NP (DT the) (NN mouse) (NN version)) (PP (IN of) (NP (NP (DT a) (NN protein)) (VP (VBN called) (S (NP (DT the) (NN interleukin-4) (NN receptor)))))))) (. .)) )
(TOP (S (NP (NN IL-4)) (VP (AUX is) (NP (NP (DT a) (NN hormone)) (SBAR (WHNP (WDT which)) (S (VP (VBZ directs) (NP (NP (DT the) (NN growth) (CC and) (NN function)) (PP (IN of) (NP (NP (JJ white) (NN blood) (NNS cells)) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (NN body) (POS 's)) (JJ immune) (NN response)))))))))))) (. .)) )
(TOP (S (NP (NP (DT The) (NN IL-4) (NN receptor)) (PP (IN on) (NP (NP (DT the) (NN surface)) (PP (IN of) (NP (JJ such) (NNS cells)))))) (VP (VBZ receives) (NP (NP (DT the) (NN hormone) (POS 's)) (NN message) (S (VP (TO to) (VP (VB rally) (NP (NP (DT the) (NN body) (POS 's)) (NN defense))))))) (. .)) )
(TOP (S (CC But) (PP (IN in) (NP (NP (JJ certain) (NNS conditions)) (PP (JJ such) (IN as) (NP (NP (JJ autoimmune) (NNS diseases)) (CC and) (NP (NNS allergies)) (CC and) (NP (NN transplant) (NN rejection)))))) (, ,) (NP (NNS doctors)) (VP (MD would) (VP (VB like) (S (VP (TO to) (VP (VB damp) (NP (DT the) (JJ immune) (NN response)) (SBAR (IN so) (S (NP (JJ such) (NNS cells)) (VP (AUX do) (RB n't) (VP (VB touch) (PRT (RP off)) (NP (NP (JJ harmful) (JJ inflammatory) (NNS reactions)) (CC or) (NP (NN cell) (NN destruction)))))))))))) (. .)) )
(TOP (S (S (NP (NP (DT A) (JJ soluble) (NN form)) (PP (IN of) (NP (DT the) (NN receptor)))) (VP (MD might) (VP (VB turn) (PRT (RP off)) (NP (NP (DT a) (JJ specific) (NN part)) (PP (IN of) (NP (DT the) (JJ immune) (NN response)))) (PP (IN without) (NP (JJ general) (JJ immune) (NN suppression)))))) (, ,) (NP (DT the) (NN company)) (VP (VBD said)) (. .)) )
(TOP (S (NP (DT The) (NN IL-4) (NN receptor)) (VP (AUX is) (NP (NP (CD one)) (PP (IN of) (NP (NP (CD five) (JJ such) (NNS receptors)) (SBAR (S (VP (TO to) (VP (AUX be) (VP (VBN developed) (CC and) (VBN tested) (PP (IN by) (NP (NP (NNP Receptech) (NNP Corp.)) (, ,) (NP (NP (DT a) (NN spinoff)) (PP (IN of) (NP (NNP Immunex)))))) (, ,) (PP (IN through) (NP (DT a) (VBN proposed) (ADJP (QP (money ($ $) (CD 30) (CD million)))) (JJ initial) (JJ public) (NN offering)))))))))))) (. .)) )
(TOP (S (NP (NNP Immunex)) (VP (MD will) (VP (VB contract) (PP (IN with) (NP (DT the) (NN spinoff))) (S (VP (TO to) (VP (VB provide) (NP (NP (DT the) (NN research)) (, ,) (NP (NN development)) (CC and) (NP (NP (JJ initial) (NN testing)) (PP (IN of) (NP (DT the) (JJ new) (NNS agents)))))))))) (. .)) )
(TOP (S (NP (NNP Immunex)) (VP (MD will) (VP (AUX have) (NP (DT the) (NN option) (S (VP (TO to) (VP (VB buy) (PRT (RP back)) (NP (NNP Receptech) (NNS shares)) (PP (IN after) (NP (CD five) (NNS years))))))))) (. .)) )
